The MASTERKEY-265 clinical trial: Can viruses treat cancer? - 100038

Spotlight
Video

The MASTERKEY-265 clinical trial: Can viruses treat cancer?

patientpower has 2417 videos Subscribe Here

Loading........
Description: At the European Cancer Congress (ECC) 2015, Associate Professor Georgina Long, a Clinical Researcher and Medical Oncologist at Melanoma Institute Australia, University of Sydney, discusses the safety data from the phase 1b part of the MASTERKEY-265 clinical trial. MASTERKEY-265 was designed to evaluate the combination of talimogene laherparepvec (T-VEC), a herpes simplex virus-1, and pembrolizumab, a monoclonal antibody, for the treatment of patients with unresectable stage IIIB-IV melanoma.

Visit our website | http://www.patientpower.eu/...
Follow on Twitter | https://twitter.com/patient...
Like on Facebook | https://www.fb.com/patientp...
Shared By : patientpower
Posted on : 10/09/15
Added : 2 years ago



Recommended

Nothing found.